Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
-Business performance on track to achieve approximately $20 million of annualized run-rate EBITDASO1 on annualized revenues of approximately $75 million...
Financial
GE HealthCare Tops List for Third Year in a Row with Highest Number of AI-Enabled Medical Device Authorizations
FDA’s list of AI-enabled device authorizations includes more than 850 devices; 72 are from GE HealthCare – more than any...
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
New Data Presented at Heart Rhythm Society Conference Demonstrates Continued Progress with Company’s AI Program Data Show That Applying AI...
Mainz Biomed Awarded Poster of Distinction at Digestive Disease Week, Positioning the Company for its Planned FDA Trial
Mainz Biomed Presented Industry Leading Results: 97% Sensitivity for Colorectal Cancer, 82% for Advanced Precancerous Lesions The eAArly DETECT results...
AI/ML Innovations Inc. Announces Agreement with Moonshot Inc.
TORONTO, ON / ACCESSWIRE / May 17, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to...
FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization
First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patientsManassas, Virginia--(Newsfile Corp. -...
Accenture Invests in Turbine to Accelerate Use of AI-Powered Cell Simulations for Biopharma Research and Development
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) has made a strategic investment, through Accenture Ventures, in Turbine, a predictive simulation company that...
Element Science Appoints Lee Smith, Jr. as the Company’s First Head of Commercial
Mr. Smith brings 20 years of successful leadership experience in Sales, Commercial Operations, and Customer SuccessSAN FRANCISCO--(BUSINESS WIRE)--Element Science, an...
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enables Creation of an Automated TULSA Treatment Plan
– Prostate segmentation using a deep learning convolutional neural network – – Model uses 24,611,072 parameters extracted from 7,466 training...
The Association of Cancer Care Centers and Flatiron Health Announce a Strategic Collaboration to Improve Study Data Capture
Partnership to enable cancer care centers to improve access and efficiency of clinical studies and researchNEW YORK--(BUSINESS WIRE)--Flatiron Health, a...
PMD Device Solutions Signs Letter of Intent for the Coala-Life Technology for 2 MSEK Per Year with Royalties
STOCKHOLM, SWEDEN / ACCESSWIRE / May 13, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) On May 13th, PMD Device Solutions (PMDS)...
Quantum Health Awarded 2024 MedTech Breakthrough Award for Best Overall Patient Engagement Solution
Company’s healthcare navigation and care coordination platform recognized for its unique human-centered, technology-empowered design and use of AI to drive...
Mainz Biomed to Present Results of Colorectal Cancer Screening Study eAArly DETECT at Digestive Disease Week 2024 in Washington, D.C.
The eAArly DETECT results reported a sensitivity for colorectal cancer of 97% with a specificity of 97% and a sensitivity...
Cerevance Achieves First Milestone in Research Collaboration with Merck
BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system...
Unlocking the Power of AI; MUSE HEALTH and TeraCrunch Spearhead Change
Shaping a future where healthcare is accessible, efficient, and tailored to BIPOC individual needs while harnessing AI to drive efficiency,...
Dexios Sees Success in Capturing Charges on the Front-end That Would Cause Denials on the Backend
Dexios President - Billie Artcliff: ‘“From reducing coding related denials and direct-to-bill rates of over 85 percent, Maverick's solution has...
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart...
Cerevance to Participate at Upcoming Investor Conferences
BOSTON, April 29, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system...
HCA Healthcare Reports First Quarter 2024 Results
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31,...
AI in Healthcare: Unveiling the Future with a 42.20% CAGR Through 2029
USA News Group Commentary VANCOUVER, BC, April 25, 2024 /PRNewswire/ -- Across several sectors the use of artificial intelligence (AI)...